Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Active not recruiting 2Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Polycystic Ovary Syndrome 3Leukoplakia, Oral 2Insulin Resistance 2Glioblastoma 2Erythroplasia 2Endometrial Neoplasms 2Endometrial Hyperplasia 2Carcinoma, Intraductal, Noninfiltrating 2Urothelial Cancer 1Squamous Cell Carcinoma of Head and Neck 1Smoldering Multiple Myeloma 1Prostatic Neoplasms 1Prediabetic State 1Pancreatic Adenocarcinoma 1Mouth Neoplasms 1Monoclonal Gammopathy of Undetermined Significance 1Metabolic Diseases 1Lung Neoplasms 1Infertility 1Hyperplasia 1Diabetes Mellitus 1Breast Neoplasms 1Breast Carcinoma In Situ 1Advanced Solid Malignancies 1Advanced Pancreatic Cancer 1

Interventions

Metformin 2Megestrol Acetate 2Pterocarpus marsupium 1Levonorgestrel 1Everolimus 1Biopsy 13,5-dimethoxy-4'-hydroxystilbene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Endometrial Hyperplasia × Metformin × Clear all
NCT04576104 2026-01-21

Megestrol Acetate Compared With Megestrol Acetate and Metformin to Prevent Endometrial Cancer

Northwestern University

Phase 2 Active not recruiting
51 enrolled
Gynecologic

Endometrial Hyperplasia, Endometrial Neoplasms

NCT01686126 2024-08-28

feMMe

Queensland Centre for Gynaecological Cancer

Phase 2 Active not recruiting
165 enrolled
Gynecologic

Endometrial Hyperplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡